Occurrence of hepatocellular carcinoma 24 years after successful interferon therapy in a patient with chronic hepatitis C: a case report
- PMID: 30341715
- DOI: 10.1007/s12328-018-0915-8
Occurrence of hepatocellular carcinoma 24 years after successful interferon therapy in a patient with chronic hepatitis C: a case report
Abstract
An 82-year-old man presented with hepatocellular carcinomas (HCCs) 24 years after achieving a sustained virological response (SVR) to an interferon for hepatitis C. His hepatic fibrosis stage was F1 when he was treated at 58 years. He was followed-up by annual blood tests and abdominal ultrasonography or computed tomography. After the IFN treatment, he had drunk approximately 100 g of ethanol. Serum aspartate aminotransferase and gamma-glutamyl transpeptidase levels had been elevated since 2012. To investigate the possible factors that affect hepatocarcinogenesis over 10 years after achieving an SVR, we reviewed the literature. Of 39 reported patients, 26, as well as ours, had one or more lifestyle-related factors, including body mass index ≥ 25 kg/m2, diabetes mellitus, impaired glucose tolerance, hepatosteatosis, or alcohol consumption. In our patient, aging and daily alcohol consumption might have triggered the development of HCCs.
Keywords: Alcohol consumption; Body mass index; Diabetes mellitus; Hepatosteatosis; Sustained virological response.
Similar articles
-
Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C.Intern Med. 2020 Aug 1;59(15):1855-1860. doi: 10.2169/internalmedicine.4479-20. Epub 2020 Apr 30. Intern Med. 2020. PMID: 32350199 Free PMC article.
-
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.J Hepatol. 2017 Mar;66(3):504-513. doi: 10.1016/j.jhep.2016.10.028. Epub 2016 Nov 4. J Hepatol. 2017. PMID: 27818234
-
Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.J Viral Hepat. 2017 Jun;24(6):472-476. doi: 10.1111/jvh.12665. Epub 2017 Jan 11. J Viral Hepat. 2017. PMID: 27983762
-
Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.Viruses. 2018 Sep 28;10(10):531. doi: 10.3390/v10100531. Viruses. 2018. PMID: 30274202 Free PMC article. Review.
-
Hepatitis C and interferon: fewer cases of liver cancer.Prescrire Int. 2013 Jul;22(140):191. Prescrire Int. 2013. PMID: 23951600 Review.
Cited by
-
Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis.Pharmaceuticals (Basel). 2024 Feb 19;17(2):260. doi: 10.3390/ph17020260. Pharmaceuticals (Basel). 2024. PMID: 38399475 Free PMC article.
-
Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy.Case Reports Hepatol. 2020 Oct 14;2020:8824974. doi: 10.1155/2020/8824974. eCollection 2020. Case Reports Hepatol. 2020. PMID: 33123390 Free PMC article.
-
Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C.Intern Med. 2020 Aug 1;59(15):1855-1860. doi: 10.2169/internalmedicine.4479-20. Epub 2020 Apr 30. Intern Med. 2020. PMID: 32350199 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical